Previous studies have shown a negative correlation between PHD3 expression and cell invasiveness through MatrigelTM, indicating that PHD3 loss may promote mesenchymal and/or metastatic properties in cancer cells[9]. This evidence concerns the gene EGLN3 and cancer.